{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:28:03Z","timestamp":1792477683051,"version":"4.5.0"},"reference-count":251,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010124","name":"Erich und Gertrud Roggenbuck-Stiftung","doi-asserted-by":"publisher","award":["0424\/108"],"award-info":[{"award-number":["0424\/108"]}],"id":[{"id":"10.13039\/100010124","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Despite the successes achieved in recent years in the treatment of childhood acute lymphoblastic leukemia (ALL), high-risk ALL in particular still represents a considerable challenge, with poorer outcomes. The PI3K\/AKT\/mTOR signaling pathway is frequently constitutively activated in ALL and consequently leads to unrestricted cell proliferation, without showing frequent mutations in the most important representatives of the signaling pathway. Recent studies have shown that fine balanced protein expression is a common way to adjust oncogenic B cell directed receptor signaling and to mediate malignant cell proliferation and survival in leukemic cells. Too low expression of inhibitory phosphatases can lead to constitutive signaling of kinases, which are important for cell proliferation and survival. In contrast, marked high expression levels of key phosphatases enable cells with distinct pronounced oncogenic B cell directed receptor signaling to escape negative selection by attenuating signal strength and thus raising the threshold for deletion checkpoint activation. One of the most important B cell receptor-dependent signaling cascades is the PI3K\/AKT signaling pathway, with its important antagonist SHIP1. However, recent data show that the inositol-5-phosphatase SHIP1 is differentially expressed across the heterogeneity of the ALL subtypes, making the overall therapeutic strategy targeting SHIP1 more complex. The aim of this article is therefore to provide an overview of the current knowledge about SHIP1, its expression in the various subtypes of ALL, its regulation, and the molecules that influence its gene and protein expression, to better understand its role in the pathogenesis of leukemia and other human cancers.<\/jats:p>","DOI":"10.3390\/ijms26146935","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T09:33:53Z","timestamp":1753090433000},"page":"6935","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Inositol-5-Phosphatase SHIP1: Expression, Regulation and Role in Acute Lymphoblastic Leukemia"],"prefix":"10.3390","volume":"26","author":[{"given":"Patrick","family":"Ehm","sequence":"first","affiliation":[{"name":"Institute of Biochemistry and Signal Transduction, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-6526","authenticated-orcid":false,"given":"Manfred","family":"J\u00fccker","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry and Signal Transduction, Center for Experimental Medicine, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","article-title":"Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition","volume":"124","author":"Irving","year":"2014","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"110301","DOI":"10.1016\/j.cellsig.2022.110301","article-title":"Investigation of the function of the PI3-Kinase\/AKT signaling pathway for leukemogenesis and therapy of acute childhood lymphoblastic leukemia (ALL)","volume":"93","author":"Ehm","year":"2022","journal-title":"Cell. Signal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41417-022-00491-0","article-title":"Functional characterization of the PI3K\/AKT\/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia","volume":"29","author":"Uhl","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100015","DOI":"10.1016\/j.bneo.2024.100015","article-title":"Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells","volume":"1","author":"Imanaga","year":"2024","journal-title":"Blood Neoplasia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41573-021-00209-1","article-title":"PI3K inhibitors are finally coming of age","volume":"20","author":"Vanhaesebroeck","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101430","DOI":"10.1016\/j.gendis.2024.101430","article-title":"Oncogenic activation of PIK3CA in cancers: Emerging targeted therapies in precision oncology","volume":"12","author":"Wang","year":"2024","journal-title":"Genes Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3324\/haematol.2013.096438","article-title":"Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K\/Akt pathway despite high PTEN protein levels","volume":"99","author":"Gomes","year":"2014","journal-title":"Haematologica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12964-024-01732-5","article-title":"Ikaros sets the threshold for negative B-cell selection by regulation of the signaling strength of the AKT pathway","volume":"22","author":"Ehm","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Franks, S.E., and Cambier, J.C. (2018). Putting on the Brakes: Regulatory Kinases and Phosphatases Maintaining B Cell Anergy. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00665"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1073\/pnas.1704706114","article-title":"PI3K-p110\u03b1 mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85\u03b1","volume":"114","author":"Thorpe","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Pungsrinont, T., Kallenbach, J., and Baniahmad, A. (2021). Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011088"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1600-065X.2009.00838.x","article-title":"Phosphoinositide 3-kinase-regulated adapters in lymphocyte activation","volume":"232","author":"Zhang","year":"2009","journal-title":"Immunol. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cellsig.2007.12.004","article-title":"PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB\/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity","volume":"20","author":"Ma","year":"2008","journal-title":"Cell. Signal."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.molcel.2018.07.035","article-title":"Quantitative Lipid Imaging Reveals a New Signaling Function of Phosphatidylinositol-3,4-Bisphophate: Isoform- and Site-Specific Activation of Akt","volume":"71","author":"Liu","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Srivastava, N., Sudan, R., and Kerr, W.G. (2013). Role of inositol poly-phosphatases and their targets in T cell biology. Front. Immunol., 4.","DOI":"10.3389\/fimmu.2013.00288"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shorning, B.Y., Dass, M.S., Smalley, M.J., and Pearson, H.B. (2020). The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124507"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Devanathan, N., Jones, S., Kaur, G., and Kimble-Hill, A.C. (2020). Using Phosphatidylinositol Phosphorylation as Markers for Hyperglycemic Related Breast Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072320"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhang, M., Ceyhan, Y., Mei, S., Hirz, T., Sykes, D.B., and Agoulnik, I.U. (2023). Regulation of EZH2 Expression by INPP4B in Normal Prostate and Primary Prostate Cancer. Cancers, 15.","DOI":"10.3390\/cancers15225418"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pbc.24034","article-title":"Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia","volume":"59","author":"Morishita","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-018-1043-6","article-title":"Akt2 mediates glucocorticoid resistance in lymphoid malignancies through FoxO3a\/Bim axis and serves as a direct target for resistance reversal","volume":"9","author":"Xie","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, L., Zhou, S., Zhou, T., Li, X., and Tang, J. (2022). Targeting the lncRNA DUXAP8\/miR-29a\/PIK3CA Network Restores Doxorubicin Chemosensitivity via PI3K-AKT-mTOR Signaling and Synergizes With Inotuzumab Ozogamicin in Chemotherapy-Resistant B-Cell Acute Lymphoblastic Leukemia. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.773601"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-023-38456-y","article-title":"Dasatinib overcomes glucocorticoid resistance in B-cell acute lymphoblastic leukemia","volume":"14","author":"Sarno","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1073\/pnas.93.4.1689","article-title":"The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase","volume":"93","author":"Damen","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Diop, A., Santorelli, D., Malagrin\u00f2, F., Nardella, C., Pennacchietti, V., Pagano, L., Marcocci, L., Pietrangeli, P., Gianni, S., and Toto, A. (2022). SH2 Domains: Folding, Binding and Therapeutical Approaches. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415944"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bates, L., Wiseman, E., Whetzel, A., and Carroll, D.J. (2024). A Novel Method to Profile Transcripts Encoding SH2 Domains in the Patiria miniata Mature Egg Transcriptome. Cells, 13.","DOI":"10.3390\/cells13221898"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mehra, S., Nicholls, M., and Taylor, J. (2024). The Evolving Role of Bruton\u2019s Tyrosine Kinase Inhibitors in B Cell Lymphomas. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25147516"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"L\u2019Estrange-Stranieri, E., Gottschalk, T.A., Wright, M.D., and Hibbs, M.L. (2024). The dualistic role of Lyn tyrosine kinase in immune cell signaling: Implications for systemic lupus erythematosus. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1395427"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.molcel.2021.03.043","article-title":"Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer","volume":"81","author":"Sadras","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"110331","DOI":"10.1016\/j.cellsig.2022.110331","article-title":"SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies","volume":"94","author":"Leveille","year":"2022","journal-title":"Cell. Signal."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Seiler, C., Stainthorp, A.K., Ketchen, S., Jones, C.M., Marks, K., Quirke, P., and Ladbury, J.E. (2022). The Grb2 splice variant, Grb3-3, is a negative regulator of RAS activation. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-03985-7"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Harwood, S.J., Smith, C.R., Lawson, J.D., and Ketcham, J.M. (2023). Selected Approaches to Disrupting Protein\u2013Protein Interactions within the MAPK\/RAS Pathway. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087373"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tkachenko, A., Kupcova, K., and Havranek, O. (2024). B-Cell Receptor Signaling and Beyond: The Role of Ig\u03b1 (CD79a)\/Ig\u03b2 (CD79b) in Normal and Malignant B Cells. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010010"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hamdan, T.A., Lang, P.A., and Lang, K.S. (2020). The Diverse Functions of the Ubiquitous Fc\u03b3 Receptors and Their Unique Constituent, FcR\u03b3 Subunit. Pathogens, 9.","DOI":"10.3390\/pathogens9020140"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Fei, C., Zwozdesky, M.A., and Stafford, J.L. (2020). A Fish Leukocyte Immune-Type Receptor Uses a Novel Intracytoplasmic Tail Networking Mechanism to Cross-Inhibit the Phagocytic Response. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21145146"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ana.26507","article-title":"Impaired B Cell Expression of the Inhibitory Fc\u03b3 Receptor IIB in Myasthenia Gravis","volume":"92","author":"Keller","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gl\u00fcck, M., Dally, L., J\u00fccker, M., and Ehm, P. (2022). JAK2-V617F is a negative regulation factor of SHIP1 protein and thus influences the AKT signaling pathway in patients with Myeloproliferative neoplasm (MPN). Int. J. Biochem. Cell Biol., 149.","DOI":"10.1016\/j.biocel.2022.106229"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ehm, P., Bettin, B., and J\u00fccker, M. (2023). Activated Src kinases downstream of BCR-ABL and Flt3 induces proteasomal degradation of SHIP1 by phosphorylation of tyrosine 1021. Biochim. Biophys. Acta Mol. Cell Res., 1870.","DOI":"10.1016\/j.bbamcr.2023.119467"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Padarti, A., Abou-Fadel, J., and Zhang, J. (2021). Resurgence of phosphotyrosine binding domains: Structural and functional properties essential for understanding disease pathogenesis. Biochim. Biophys. Acta Gen. Subj., 1865.","DOI":"10.1016\/j.bbagen.2021.129977"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1042\/BST0320785","article-title":"The role of SHIP1 in macrophage programming and activation","volume":"32","author":"Rauh","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/kinasesphosphatases1010004","article-title":"Lyn Kinase Structure, Regulation, and Involvement in Neurodegenerative Diseases: A Mini Review","volume":"1","author":"Weerawarna","year":"2023","journal-title":"Kinases Phosphatases"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/MCB.17.8.4305","article-title":"Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif","volume":"17","author":"Tridandapani","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4049\/jimmunol.2100218","article-title":"FCRL1 Regulates B Cell Receptor-Induced ERK Activation through GRB2","volume":"207","author":"DeLuca","year":"2021","journal-title":"J. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Olufunmilayo, E.O., and Holsinger, R.M.D. (2023). INPP5D\/SHIP1: Expression, Regulation and Roles in Alzheimer\u2019s Disease Pathophysiology. Genes, 14.","DOI":"10.3390\/genes14101845"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/bbrc.1996.1161","article-title":"Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase","volume":"225","author":"Drayer","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1182\/blood.V89.6.1876","article-title":"The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood","volume":"89","author":"Geier","year":"1997","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/sj.leu.2401990","article-title":"The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro","volume":"15","author":"Horn","year":"2001","journal-title":"Leukemia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cell.2008.07.047","article-title":"Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation","volume":"134","author":"Filippakopoulos","year":"2008","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.sbi.2009.10.001","article-title":"SH2 domains: Modulators of nonreceptor tyrosine kinase activity","volume":"19","author":"Filippakopoulos","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"D1210","DOI":"10.1093\/nar\/gkad986","article-title":"COSMIC: A curated database of somatic variants and clinical data for cancer","volume":"52","author":"Sondka","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.cellsig.2012.07.017","article-title":"Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K\/AKT signaling","volume":"24","author":"Brauer","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1074\/jbc.RA120.013976","article-title":"The GTPase-activating protein p120RasGAP has an evolutionarily conserved \u201cFLVR-unique\u201d SH2 domain","volume":"295","author":"Wang","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"109380","DOI":"10.1016\/j.cellsig.2019.109380","article-title":"Analysis of the FLVR motif of SHIP1 and its importance for the protein stability of SH2 containing signaling proteins","volume":"63","author":"Ehm","year":"2019","journal-title":"Cell. Signal."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood.V90.10.3996","article-title":"Structural and functional basis for JAK3-deficient severe combined immunodeficiency","volume":"90","author":"Candotti","year":"1997","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"34515","DOI":"10.1074\/jbc.274.49.34515","article-title":"Temperature-sensitive ZAP70 mutants degrading through a proteasome-independent pathway. Restoration of a kinase domain mutant by Cdc37","volume":"274","author":"Matsuda","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/prot.21970","article-title":"Genome wide analysis of pathogenic SH2 domain mutations","volume":"72","author":"Lappalainen","year":"2008","journal-title":"Proteins"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1007\/s11030-024-10880-2","article-title":"Determination of promising inhibitors for N-SH2 domain of SHP2 tyrosine phosphatase: An in silico study","volume":"28","year":"2024","journal-title":"Mol. Divers."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gku1267","article-title":"PhosphoSitePlus, 2014: Mutations, PTMs and recalibrations","volume":"43","author":"Hornbeck","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.febslet.2012.05.045","article-title":"Regulatory modules: Coupling protein stability to phopshoregulation during cell division","volume":"586","author":"Holt","year":"2012","journal-title":"FEBS Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.str.2024.01.005","article-title":"Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2","volume":"32","author":"Bradshaw","year":"2024","journal-title":"Structure"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"M\u00fcller, S.M., Nelson, N., and J\u00fccker, M. (2025). Functional Characterization of the SHIP1-Domains Regarding Their Contribution to Inositol 5-Phosphatase Activity. Biomolecules, 15.","DOI":"10.3390\/biom15010105"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1096\/fj.11-201475","article-title":"A pleckstrin homology-related domain in SHIP1 mediates membrane localization during Fc\u03b3 receptor-induced phagocytosis","volume":"26","author":"Shojania","year":"2012","journal-title":"FASEB J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"110485","DOI":"10.1016\/j.cellsig.2022.110485","article-title":"Reduced expression and activity of patient-derived SHIP1 phosphatase domain mutants","volume":"101","author":"Ehm","year":"2023","journal-title":"Cell. Signal."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/eji.201646795","article-title":"Regulation of immune cell signaling by SHIP1: A phosphatase, scaffold protein, and potential therapeutic target","volume":"47","author":"Pauls","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"34839","DOI":"10.1074\/jbc.M110.128827","article-title":"A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5\u2032-phosphatase (SHIP1)","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Xie, X., Hu, L., Mi, B., Panayi, A.C., Xue, H., Hu, Y., Liu, G., Chen, L., Yan, C., and Zha, K. (2022). SHIP1 Activator AQX-1125 Regulates Osteogenesis and Osteoclastogenesis Through PI3K\/Akt and NF-\u03bab Signaling. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.826023"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"104170","DOI":"10.1016\/j.isci.2022.104170","article-title":"Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microglia","volume":"25","author":"Pedicone","year":"2022","journal-title":"iScience"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/1078-0432.CCR-19-2202","article-title":"Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells","volume":"26","author":"Lemm","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1182\/blood-2012-01-403162","article-title":"Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT","volume":"119","author":"Negro","year":"2012","journal-title":"Blood"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbamcr.2011.11.019","article-title":"The SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: Impact on SHIP1\/Ig-\u03b1 interaction","volume":"1823","author":"Mukherjee","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.exphem.2010.03.010","article-title":"Tyrosine phosphorylation of SHIP promotes its proteasomal degradation","volume":"38","author":"Ruschmann","year":"2010","journal-title":"Exp. Hematol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Waddell, G.L., Drew, E.E., Rupp, H.P., and Hansen, S.D. (2023). Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2023.105022"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"M\u00fcller, S.M., and J\u00fccker, M. (2024). The Functional Roles of the Src Homology 2 Domain-Containing Inositol 5-Phosphatases SHIP1 and SHIP2 in the Pathogenesis of Human Diseases. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105254"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cellsig.2011.07.012","article-title":"The inositol 5-phosphatase SHIP1 is a nucleo-cytoplasmic shuttling protein and enzymatically active in cell nuclei","volume":"24","author":"Nalaskowski","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cellsig.2018.05.006","article-title":"Nuclear accumulation of SHIP1 mutants derived from AML patients leads to increased proliferation of leukemic cells","volume":"49","author":"Nalaskowski","year":"2018","journal-title":"Cell. Signal."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/19491034.2015.1022701","article-title":"The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies","volume":"6","author":"Ehm","year":"2015","journal-title":"Nucleus"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ab.2012.06.001","article-title":"A toolkit for graded expression of green fluorescent protein fusion proteins in mammalian cells","volume":"428","author":"Nalaskowski","year":"2012","journal-title":"Anal. Biochem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase (PI3K) pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Papa, A., and Pandolfi, P.P. (2019). The PTEN\u2013PI3K Axis in Cancer. Biomolecules, 9.","DOI":"10.20944\/preprints201904.0127.v1"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Liu, L., Graff, S.L., and Wang, Y. (2025). New Emerging Therapies Targeting PI3K\/AKT\/mTOR\/PTEN Pathway in Hormonal Receptor-Positive and HER2-Negative Breast Cancer\u2014Current State and Molecular Pathology Perspective. Cancers, 17.","DOI":"10.3390\/cancers17010016"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Badoiu, S.C., Greabu, M., Miricescu, D., Stanescu-Spinu, I.-I., Ilinca, R., Balan, D.G., Balcangiu-Stroescu, A.-E., Mihai, D.-A., Vacaroiu, I.A., and Stefani, C. (2023). PI3K\/AKT\/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL\/HIF Axis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098391"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Leiphrakpam, P.D., and Are, C. (2024). PI3K\/Akt\/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063178"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Zhong, H., Zhou, Z., Wang, H., Wang, R., Shen, K., Huang, R., and Wang, Z. (2024). The Biological Roles and Clinical Applications of the PI3K\/AKT Pathway in Targeted Therapy Resistance in HER2-Positive Breast Cancer: A Comprehensive Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413376"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Versari, I., Salucci, S., Bavelloni, A., Battistelli, M., Traversari, M., Wang, A., Sampaolesi, M., and Faenza, I. (2025). The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma. Biomolecules, 15.","DOI":"10.3390\/biom15030334"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Garg, P., Ramisetty, S., Nair, M., Kulkarni, P., Horne, D., Salgia, R., and Singhal, S.S. (2025). Strategic advancements in targeting the PI3K\/AKT\/mTOR pathway for Breast cancer therapy. Biochem. Pharmacol., 236.","DOI":"10.1016\/j.bcp.2025.116850"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1200\/JCO.24.00427","article-title":"US Food and Drug Administration Approval Summary: Capivasertib With Fulvestrant for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer With PIK3CA\/AKT1\/PTEN Alterations","volume":"42","author":"Dilawari","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/leu.2011.129","article-title":"A novel ABL1 fusion to the SH2 containing inositol phosphatase-1 (SHIP1) in acute lymphoblastic leukemia (ALL)","volume":"25","author":"Kakadia","year":"2011","journal-title":"Leukemia"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1097\/MPH.0000000000001267","article-title":"Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib Treatment","volume":"41","author":"Poukka","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Fernandes, S., Srivastava, N., Sudan, R., Middleton, F.A., Shergill, A.K., Ryan, J.C., and Kerr, W.G. (2018). SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn\u2019s Disease and Peripheral T Cell Reduction. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01100"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Chouvarine, P., Anti\u0107, \u017d., Lentes, J., Schr\u00f6der, C., Alten, J., Br\u00fcggemann, M., Carrillo-de Santa Pau, E., Illig, T., Laguna, T., and Schewe, D. (2021). Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics. Cancers, 13.","DOI":"10.3390\/cancers13225653"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm.4062","article-title":"PTEN opposes negative selection and enables oncogenic transformation of pre-B cells","volume":"22","author":"Shojaee","year":"2016","journal-title":"Nat. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1073\/pnas.0902636106","article-title":"Inositol phosphatase SHIP1 is a primary target of miR-155","volume":"106","author":"Chaudhuri","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/eji.200940002","article-title":"Concerted action of Helios and Ikaros controls the expression of the inositol 5-phosphatase SHIP","volume":"40","author":"Alinikula","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood-2009-10-250217","article-title":"The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis","volume":"116","author":"Lakhanpal","year":"2010","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1128\/MCB.19.11.7473","article-title":"BCR\/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis","volume":"19","author":"Sattler","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Amarante-Mendes, G.P., Rana, A., Datoguia, T.S., Hamerschlak, N., and Brumatti, G. (2022). BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010215"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng1343","article-title":"Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia","volume":"36","author":"Hu","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/bj3480107","article-title":"pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of alphaIIbbeta3 integrin in human platelets","volume":"348","author":"Giuriato","year":"2000","journal-title":"Biochem. J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.exphem.2005.01.004","article-title":"Src family tyrosine kinases are activated by Flt3 and are involved in the proliferative effects of leukemia-associated Flt3 mutations","volume":"33","author":"Robinson","year":"2005","journal-title":"Exp. Hematol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biocel.2018.12.007","article-title":"The role of SRC family kinases in FLT3 signaling","volume":"107","author":"Kazi","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Voisset, E., Brenet, F., Lopez, S., and de Sepulveda, P. (2020). SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis. Cancers, 12.","DOI":"10.3390\/cancers12071996"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/asheducation-2018.1.137","article-title":"Genetics and prognosis of ALL in children vs adults","volume":"2018","author":"Roberts","year":"2018","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_107","first-page":"1438","article-title":"TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein\/Jun kinase (SAPK\/JNK), and p38 signaling pathways","volume":"100","author":"Ho","year":"2002","journal-title":"Blood"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2017.301","article-title":"Therapeutic targeting of CK2 in acute and chronic leukemias","volume":"32","author":"Buontempo","year":"2018","journal-title":"Leukemia"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1021\/acs.jmedchem.2c01887","article-title":"Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3\u03b2 and DYRK1A Kinases: A Structural Perspective","volume":"66","author":"Grygier","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/kinasesphosphatases1040015","article-title":"Exploring Protein Kinase CK2 Substrate Recognition and the Dynamic Response of Substrate Phosphorylation to Kinase Modulation","volume":"1","author":"Cesaro","year":"2023","journal-title":"Kinases Phosphatases"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cels.2024.05.005","article-title":"The substrate quality of CK2 target sites has a determinant role on their function and evolution","volume":"15","author":"Bradley","year":"2024","journal-title":"Cell Syst."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1515\/hsz-2011-0209","article-title":"Nucleocytoplasmic shuttling of human inositol phosphate multikinase is influenced by CK2 phosphorylation","volume":"393","author":"Meyer","year":"2012","journal-title":"Biol. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1248\/bpb.27.1895","article-title":"Casein kinase 2 (CK2)-mediated reduction of the activities of Src family tyrosine kinases in vitro","volume":"27","author":"Yokoyama","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2004-09-3667","article-title":"Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia","volume":"106","author":"Stam","year":"2005","journal-title":"Blood"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00262-022-03303-4","article-title":"Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement","volume":"72","author":"Suematsu","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"100204","DOI":"10.1016\/j.ejcped.2024.100204","article-title":"KMT2A-rearranged acute lymphoblastic leukaemia","volume":"4","author":"Kotecha","year":"2024","journal-title":"EJC Paediatr. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.3324\/haematol.2017.169870","article-title":"The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas\/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia","volume":"102","author":"Fedders","year":"2017","journal-title":"Haematologica"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1096\/fj.201902063R","article-title":"SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis","volume":"34","author":"Tang","year":"2020","journal-title":"FASEB J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.omto.2019.12.008","article-title":"miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen","volume":"16","author":"Monnot","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/emmm.200900028","article-title":"Onco-miR-155 targets SHIP1 to promote TNF\u03b1-dependent growth of B cell lymphomas","volume":"1","author":"Pedersen","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice","volume":"103","author":"Costinean","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2009-05-220814","article-title":"Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice","volume":"114","author":"Costinean","year":"2009","journal-title":"Blood"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"103124","DOI":"10.1016\/j.arcmed.2024.103124","article-title":"Deficiency of miR-155 in Leukemic B-Cells Results in Cell Cycle Arrest and Deregulation of MIR155HG\/TP53INP1\/CDKN1A\/CCND1 network","volume":"56","author":"Golovina","year":"2025","journal-title":"Arch. Med. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/leu.2014.231","article-title":"NF-\u03baB\/STAT5\/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia","volume":"29","author":"Gerloff","year":"2015","journal-title":"Leukemia"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Trino, S., Lamorte, D., Caivano, A., Laurenzana, I., Tagliaferri, D., Falco, G., Del Vecchio, L., Musto, P., and De Luca, L. (2018). MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020460"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Ostrycharz, E., and Hukowska-Szematowicz, B. (2022). Micro-Players of Great Significance\u2014Host microRNA Signature in Viral Infections in Humans and Animals. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810536"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Conserva, M.R., Redavid, I., Anelli, L., Zagaria, A., Tarantini, F., Cumbo, C., Tota, G., Parciante, E., Coccaro, N., and Minervini, C.F. (2023). IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043282"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Paolino, J., Tsai, H.K., Harris, M.H., and Pikman, Y. (2024). IKZF1 Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010089"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1182\/blood-2015-06-651505","article-title":"Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia","volume":"126","author":"Song","year":"2015","journal-title":"Blood"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.molcel.2023.06.012","article-title":"Transcription factors interact with RNA to regulate genes","volume":"83","author":"Oksuz","year":"2023","journal-title":"Mol. Cell"},{"key":"ref_132","first-page":"285","article-title":"The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma","volume":"25","author":"Lu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Yang, Y., Han, X., Sun, L., Shao, F., Yin, Y., and Zhang, W. (2024). ETS Transcription Factors in Immune Cells and Immune-Related Diseases. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251810004"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Ma, Y., Xu, B., Yu, J., Huang, L., Zeng, X., Shen, X., Ren, C., Ben-David, Y., and Luo, H. (2020). Fli-1 Activation through Targeted Promoter Activity Regulation Using a Novel 3\u2032, 5\u2032-diprenylated Chalcone Inhibits Growth and Metastasis of Prostate Cancer Cells. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062216"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Oda, Y., Kasakura, K., Fujigaki, I., Kageyama, A., Okumura, K., Ogawa, H., Yashiro, T., and Nishiyama, C. (2018). The effect of PU.1 knockdown on gene expression and function of mast cells. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-19378-y"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41591-022-02112-7","article-title":"Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response","volume":"29","author":"Lee","year":"2023","journal-title":"Nat. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Ehm, P., Rietow, R., Wegner, W., Bu\u00dfmann, L., Kriegs, M., Dierck, K., Horn, S., Streichert, T., Horstmann, M., and J\u00fccker, M. (2023). SHIP1 Is Present but Strongly Downregulated in T-ALL, and after Restoration Suppresses Leukemia Growth in a T-ALL Xenotransplantation Mouse Model. Cells, 12.","DOI":"10.3390\/cells12131798"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1182\/blood-2017-09-808402","article-title":"Five percent of healthy newborns have an ETV6-RUNX1 fusion as revealed by DNA-based GIPFEL screening","volume":"131","author":"Olsen","year":"2018","journal-title":"Blood"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood-2010-03-275347","article-title":"ETV6\/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling","volume":"117","author":"Kuster","year":"2011","journal-title":"Blood"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Monta\u00f1o, A., Ordo\u00f1ez, J.L., Alonso-P\u00e9rez, V., Hern\u00e1ndez-S\u00e1nchez, J., Santos, S., Gonz\u00e1lez, T., Benito, R., Garc\u00eda-Tu\u00f1\u00f3n, I., and Hern\u00e1ndez-Rivas, J.M. (2020). ETV6\/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia. Cells, 9.","DOI":"10.3390\/cells9010215"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/stem.2700","article-title":"RUNX1c Regulates Hematopoietic Differentiation of Human Pluripotent Stem Cells Possibly in Cooperation with Proinflammatory Signaling","volume":"35","author":"Ayllon","year":"2017","journal-title":"Stem Cells"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc840","article-title":"Core-binding factors in haematopoiesis and leukaemia","volume":"2","author":"Speck","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1182\/bloodadvances.2020003969","article-title":"Redundant mechanisms driven independently by RUNX1 and GATA2 for hematopoietic development","volume":"5","author":"Bresciani","year":"2021","journal-title":"Blood Adv."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41467-024-44913-z","article-title":"Runx1+ vascular smooth muscle cells are essential for hematopoietic stem and progenitor cell development in vivo","volume":"15","author":"Kilpatrick","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"8242","DOI":"10.1073\/pnas.112218799","article-title":"Chromosome translocations and covert leukemic clones are generated during normal fetal development","volume":"99","author":"Mori","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrc1164","article-title":"Origins of chromosome translocations in childhood leukaemia","volume":"3","author":"Greaves","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_149","first-page":"826","article-title":"The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells","volume":"119","author":"Ford","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2141.2008.07261.x","article-title":"An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: The Microarray Innovations in LEukemia study prephase","volume":"142","author":"Kohlmann","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: Report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Burmeister, T., Gr\u00f6ger, D., G\u00f6kbuget, N., Spriewald, B., Starck, M., Elmaagacli, A., Hoelzer, D., Keller, U., and Schwartz, S. (2023). Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-42294-9"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e70071","DOI":"10.1002\/hem3.70071","article-title":"Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure","volume":"9","author":"Kusterer","year":"2025","journal-title":"Hemasphere"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-\u03b1 (IL7R) in childhood acute lymphoblastic leukemias","volume":"208","author":"Shochat","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Horv\u00e1th, M., Kert\u00e9sz, G., Kassa, C., Goda, V., Csord\u00e1s, K., Hau, L., K\u00f6v\u00e9r, A., Str\u00e9hn, A., Horv\u00e1th, O., and K\u00e1llay, K. (2022). Peripheral Bone Relapse of Paediatric TCF3-HLF Positive Acute Lymphoblastic Leukaemia during Haematopoietic Stem Cell Transplantation: A Case Report. Children, 9.","DOI":"10.3390\/children9121919"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e00663-19","DOI":"10.1128\/MCB.00663-19","article-title":"TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation","volume":"40","author":"Fan","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"de Martin, X., Sodaei, R., and Santpere, G. (2021). Mechanisms of Binding Specificity among bHLH Transcription Factors. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179150"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1039\/C4MB00672K","article-title":"Shared structural features of the 9aaTAD family in complex with CBP","volume":"11","author":"Piskacek","year":"2015","journal-title":"Mol. Biosyst."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Crisafulli, L., Brindisi, M., Liturri, M.G., Sobacchi, C., and Ficara, F. (2024). PBX1: A TALE of two seasons-key roles during development and in cancer. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1372873"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41375-024-02333-4","article-title":"Rearrangements involving 11q23.3\/KMT2A in adult AML: Mutational landscape and prognostic implications-a HARMONY study","volume":"38","author":"Sobas","year":"2024","journal-title":"Leukemia"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nm.3832","article-title":"DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia","volume":"21","author":"Chen","year":"2015","journal-title":"Nat. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exphem.2016.11.003","article-title":"MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation","volume":"47","author":"Godfrey","year":"2017","journal-title":"Exp. Hematol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e26594","DOI":"10.1002\/pbc.26594","article-title":"Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement","volume":"64","author":"Zoghbi","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stemcr.2019.12.009","article-title":"Enhancing Hematopoiesis from Murine Embryonic Stem Cells through MLL1-Induced Activation of a Rac\/Rho\/Integrin Signaling Axis","volume":"14","author":"Yang","year":"2020","journal-title":"Stem Cell Rep."},{"key":"ref_166","first-page":"889","article-title":"Late-developing Philadelphia chromosomes in a case of T-cell acute lymphoblastic leukemia","volume":"8","author":"Coad","year":"1994","journal-title":"Leukemia"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002770050412","article-title":"Molecular detection of a late-appearing BCR-ABL gene in a child with T-cell acute lymphoblastic leukemia","volume":"77","author":"Tchirkov","year":"1998","journal-title":"Ann. Hematol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12288-013-0314-8","article-title":"Philadelphia chromosome positive pre-T cell acute lymphoblastic leukemia: A rare case report and short review","volume":"30","author":"Verrma","year":"2014","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1515\/med-2021-0309","article-title":"Characteristics of BCR-ABL gene variants in patients of chronic myeloid leukemia","volume":"16","author":"Amin","year":"2021","journal-title":"Open Med."},{"key":"ref_170","first-page":"1866","article-title":"Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells","volume":"9","author":"McLaughlin","year":"1989","journal-title":"Mol. Cell. Biol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V78.9.2411.2411","article-title":"Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia","volume":"78","author":"Kantarjian","year":"1991","journal-title":"Blood"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41375-020-01082-4","article-title":"Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets","volume":"35","author":"Kim","year":"2021","journal-title":"Leukemia"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Padmakumar, A., Thankamony, P., Vasudevan, J.A., Gopinath, P., Chandraprabha, V.R., Devi, A.R.T.V., Anitha, G.R.J., Sreelatha, M.M., Padmakumar, D., and Sreedharan, H. (2024). Double Philadelphia chromosome: A rare and sole abnormality in pediatric B-acute lymphoblastic leukemia. 3 Biotech, 14.","DOI":"10.1007\/s13205-024-03935-6"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41375-019-0591-9","article-title":"In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent","volume":"34","author":"Baccarani","year":"2020","journal-title":"Leukemia"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e70005","DOI":"10.1002\/ardp.70005","article-title":"Structure and Dynamics of the ABL1 Tyrosine Kinase and Its Important Role in Chronic Myeloid Leukemia","volume":"358","author":"Irgit","year":"2025","journal-title":"Arch. Pharm."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and Resistance to BCR-ABL1-Targeted Therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/cncr.23666","article-title":"Kinase domain point mutations in Philadelphia chromosome-positive acute lymphoblastic leukemia emerge after therapy with BCR-ABL kinase inhibitors","volume":"113","author":"Jones","year":"2008","journal-title":"Cancer"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Saleh, K., Fernandez, A., and Pasquier, F. (2022). Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults. Cancers, 14.","DOI":"10.3390\/cancers14071805"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Navas-Acosta, J., Hern\u00e1ndez-S\u00e1nchez, A., Gonz\u00e1lez, T., Villaverde Ramiro, \u00c1., Santos, S., Miguel, C., Ribera, J., Granada, I., Morgades, M., and S\u00e1nchez, R. (2024). Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia. Cancers, 16.","DOI":"10.3390\/cancers16244200"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.07.006","article-title":"BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia","volume":"26","author":"Zabriskie","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1080\/10428194.2024.2396046","article-title":"IKZF1 in acute lymphoblastic leukemia: The rise before the fall?","volume":"65","author":"Boer","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41375-025-02633-3","article-title":"Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia","volume":"39","author":"Mullighan","year":"2025","journal-title":"Leukemia"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature14231","article-title":"Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia","volume":"521","author":"Chen","year":"2015","journal-title":"Nature"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1182\/asheducation-2016.1.561","article-title":"Ph-like acute lymphoblastic leukemia","volume":"2016","author":"Tran","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2016-07-726588","article-title":"Ph-like acute lymphoblastic leukemia: A high-risk subtype in adults","volume":"129","author":"Jain","year":"2017","journal-title":"Blood"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Zi\u0119tara, K.J., Wr\u00f3blewska, K., Zaj\u0105czkowska, M., Tacza\u0142a, J., and Lejman, M. (2024). The Role of the JAK\u2013STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25136844"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e2120787119","DOI":"10.1073\/pnas.2120787119","article-title":"Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases","volume":"119","author":"Dai","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.leukres.2009.04.032","article-title":"Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing","volume":"33","author":"Lo","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Berm\u00fadez Brito, M., Goulielmaki, E., and Papakonstanti, E.A. (2015). Focus on PTEN Regulation. Front. Oncol., 5.","DOI":"10.3389\/fonc.2015.00166"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Garc\u00eda, A., Garrido, A., and Carrera, A.C. (2022). Targeting PTEN Regulation by Post Translational Modifications. Cancers, 14.","DOI":"10.3390\/cancers14225613"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/jcp.31053","article-title":"The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets","volume":"238","author":"Liu","year":"2023","journal-title":"J. Cell. Physiol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","article-title":"The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease","volume":"92","author":"Bose","year":"1998","journal-title":"Blood"},{"key":"ref_199","doi-asserted-by":"crossref","unstructured":"Smeets, M.F., Chan, A.C., Dagger, S., Bradley, C.K., Wei, A., and Izon, D.J. (2013). Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia\/lymphoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062346"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng.858","article-title":"A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)","volume":"43","author":"Mavrakis","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.20122516","article-title":"The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia","volume":"210","author":"Mansour","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Wu, W., Nie, L., Zhang, L., and Li, Y. (2018). The notch pathway promotes NF-\u03baB activation through Asb2 in T cell acute lymphoblastic leukemia cells. Cell. Mol. Biol. Lett., 23.","DOI":"10.1186\/s11658-018-0102-4"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Toribio, M.L., and Gonz\u00e1lez-Garc\u00eda, S. (2023). Notch Partners in the Long Journey of T-ALL Pathogenesis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021383"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1074\/jbc.M309924200","article-title":"The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt\/PKB-mediated signaling in T cells","volume":"279","author":"Sade","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Schaks, M., Allgoewer, K., Nelson, N., Ehm, P., Heumann, A., Ewald, F., Schumacher, U., Simon, R., Sauter, G., and J\u00fccker, M. (2020). Ectopic Expression of Hematopoietic SHIP1 in Human Colorectal Cancer. Biomedicines, 8.","DOI":"10.3390\/biomedicines8070215"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"110720","DOI":"10.1016\/j.cellsig.2023.110720","article-title":"Targeted hyperactivation of AKT through inhibition of ectopic expressed SHIP1 induces cell death in colon carcinoma cells and derived metastases","volume":"108","author":"Ehm","year":"2023","journal-title":"Cell. Signal."},{"key":"ref_207","first-page":"2337","article-title":"SHIP1 inhibits cell growth, migration, and invasion in non-small cell lung cancer through the PI3K\/AKT pathway","volume":"41","author":"Fu","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1158\/1078-0432.CCR-09-1431","article-title":"Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer","volume":"15","author":"Jorissen","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1158\/0008-5472.CAN-08-2690","article-title":"Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest","volume":"69","author":"Bailet","year":"2009","journal-title":"Cancer Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2009.06.006","article-title":"Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling","volume":"16","author":"Gewinner","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI40535","article-title":"A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis","volume":"120","author":"Alimonti","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature05327","article-title":"Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication","volume":"444","author":"Fumagalli","year":"2006","journal-title":"Nature"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Lee, C.S., Baek, J., and Han, S.-Y. (2017). The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment. Molecules, 22.","DOI":"10.3390\/molecules22091411"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/aps.2017.198","article-title":"Oncogene-induced senescence: A double edged sword in cancer","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41418-019-0384-8","article-title":"A functional genetic screen defines the AKT-induced senescence signaling network","volume":"27","author":"Chan","year":"2020","journal-title":"Cell Death Differ."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41586-024-07797-z","article-title":"Titration of RAS alters senescent state and influences tumour initiation","volume":"633","author":"Chan","year":"2024","journal-title":"Nature"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"Srinivasan","year":"2009","journal-title":"Cell"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Le, Y., Zhu, S., Peng, H., and Wang, Z. (2025). Unveiling the omics tapestry of B-acute lymphoblastic leukemia: Bridging genomics, metabolomics, and immunomics. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-87684-3"},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Burnet, F.M. (1959). The Clonal Selection Theory of Acquired Immunity, Cambridge University Press.","DOI":"10.5962\/bhl.title.8281"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/s41467-017-01850-4","article-title":"Checkpoint kinase 1 is essential for normal B cell development and lymphomagenesis","volume":"8","author":"Schuler","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ccell.2015.05.008","article-title":"Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia","volume":"28","author":"Shojaee","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/s41467-021-23752-2","article-title":"Targeted PI3K\/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia","volume":"12","author":"Ecker","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/BST20190775","article-title":"Small molecule targeting of SHIP1 and SHIP2","volume":"48","author":"Kerr","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"C569","DOI":"10.1152\/ajpcell.00433.2020","article-title":"Inhibition of lipid phosphatase SHIP1 expands myeloid-derived suppressor cells and attenuates rheumatoid arthritis in mice","volume":"321","author":"So","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"156373","DOI":"10.1016\/j.cyto.2023.156373","article-title":"SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection","volume":"171","author":"Chowdhury","year":"2023","journal-title":"Cytokine"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Miao, J., Lin, J., Dong, J., Amarasinghe, O., Mason, E.R., Chu, S., Qu, Z., Cullers, C.C., Putt, K.S., and Zhang, Z.Y. (2024). Discovery and evaluation of novel SHIP-1 inhibitors. Bioorg. Med. Chem., 114.","DOI":"10.1016\/j.bmc.2024.117965"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"e087553","DOI":"10.1002\/alz.087553","article-title":"Optimization of SHIP1 Inhibitors for the treatment of Alzheimer\u2019s disease","volume":"20","author":"Jesudason","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2017.06.004","article-title":"B-cell identity as a metabolic barrier against malignant transformation","volume":"53","author":"Chan","year":"2017","journal-title":"Exp. Hematol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature21076","article-title":"Metabolic gatekeeper function of B-lymphoid transcription factors","volume":"542","author":"Chan","year":"2017","journal-title":"Nature"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"13950","DOI":"10.1073\/pnas.94.25.13950","article-title":"Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots","volume":"94","author":"Gale","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(99)09403-9","article-title":"Prenatal origin of acute lymphoblastic leukaemia in children","volume":"354","author":"Wiemels","year":"1999","journal-title":"Lancet"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1182\/blood-2011-07-366542","article-title":"Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia","volume":"118","author":"Cazzaniga","year":"2011","journal-title":"Blood"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1158\/0008-5472.CAN-17-3262","article-title":"Loss of Pax5 Exploits Sca1-BCR-ABLp190 Susceptibility to Confer the Metabolic Shift Essential for pB-ALL","volume":"78","author":"Auer","year":"2018","journal-title":"Cancer Res."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood.V86.8.3118.3118","article-title":"Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals","volume":"86","author":"Biernaux","year":"1995","journal-title":"Blood"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood-2010-08-301515","article-title":"Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation","volume":"117","author":"Takagi","year":"2011","journal-title":"Blood"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"e1470","DOI":"10.1038\/cddis.2014.431","article-title":"Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cell.2018.02.048","article-title":"B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies","volume":"173","author":"Xiao","year":"2018","journal-title":"Cell"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/leu.2015.359","article-title":"Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia","volume":"30","author":"Marke","year":"2016","journal-title":"Leukemia"},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Karim, S., Burzangi, A.S., Ahmad, A., Siddiqui, N.A., Ibrahim, I.M., Sharma, P., Abualsunun, W.A., and Gabr, G.A. (2022). PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042305"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ccr.2013.10.022","article-title":"Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia","volume":"24","author":"Piovan","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"110939","DOI":"10.1016\/j.isci.2024.110939","article-title":"PI3K-dependent reprogramming of hexokinase isoforms controls glucose metabolism and functional responses of B lymphocytes","volume":"27","author":"Paradoski","year":"2024","journal-title":"iScience"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nm.4252","article-title":"Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation","volume":"23","author":"Lu","year":"2017","journal-title":"Nat. Med."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2014-08-595389","article-title":"Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia","volume":"124","author":"Orgel","year":"2014","journal-title":"Blood"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13679-023-00542-z","article-title":"Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges","volume":"13","author":"Tsilingiris","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1189\/jlb.2A0116-040RR","article-title":"Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway","volume":"101","author":"Han","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2009-10-251413","article-title":"Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia","volume":"115","author":"Bateman","year":"2010","journal-title":"Blood"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41375-023-02111-8","article-title":"Backtracking to the future: Unraveling the origins of childhood leukemia","volume":"38","author":"Wiemels","year":"2024","journal-title":"Leukemia"},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"de Smith, A.J., and Spector, L.G. (2024). In Utero Origins of Acute Leukemia in Children. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010236"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41375-022-01756-1","article-title":"Covert pre-leukaemic clones in healthy co-twins of patients with childhood acute lymphoblastic leukaemia","volume":"37","author":"Ford","year":"2023","journal-title":"Leukemia"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1101\/gad.266999.115","article-title":"Regulation of gene expression dynamics during developmental transitions by the Ikaros transcription factor","volume":"29","author":"Arenzana","year":"2015","journal-title":"Genes Dev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/6935\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:12:33Z","timestamp":1760033553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/6935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":251,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26146935"],"URL":"https:\/\/doi.org\/10.3390\/ijms26146935","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]}}}